453 related articles for article (PubMed ID: 12199724)
21. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
[TBL] [Abstract][Full Text] [Related]
22. Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures.
Hosford DA; Wang Y
Epilepsia; 1997 Apr; 38(4):408-14. PubMed ID: 9118845
[TBL] [Abstract][Full Text] [Related]
23. Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study. Gabapentin Paediatric Study Group.
Appleton R; Fichtner K; LaMoreaux L; Alexander J; Halsall G; Murray G; Garofalo E
Epilepsia; 1999 Aug; 40(8):1147-54. PubMed ID: 10448830
[TBL] [Abstract][Full Text] [Related]
24. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ;
Epilepsia; 2004 May; 45(5):410-23. PubMed ID: 15101822
[TBL] [Abstract][Full Text] [Related]
26. Advances in the pharmacotherapy of epilepsy.
Ramsay RE
Epilepsia; 1993; 34 Suppl 5():S9-16. PubMed ID: 8339715
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ;
Epilepsia; 2004 May; 45(5):401-9. PubMed ID: 15101821
[TBL] [Abstract][Full Text] [Related]
28. Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 82/83.
Beydoun A; Fischer J; Labar DR; Harden C; Cantrell D; Uthman BM; Sackellares JC; Abou-Khalil B; Ramsay RE; Hayes A; Greiner M; Garofalo E; Pierce M
Neurology; 1997 Sep; 49(3):746-52. PubMed ID: 9305335
[TBL] [Abstract][Full Text] [Related]
29. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group.
Brodie MJ; Overstall PW; Giorgi L
Epilepsy Res; 1999 Oct; 37(1):81-7. PubMed ID: 10515178
[TBL] [Abstract][Full Text] [Related]
30. Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. The International Gabapentin Study Group.
Anhut H; Ashman P; Feuerstein TJ; Sauermann W; Saunders M; Schmidt B
Epilepsia; 1994; 35(4):795-801. PubMed ID: 8082624
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ;
Neurology; 2004 Apr; 62(8):1252-60. PubMed ID: 15111659
[TBL] [Abstract][Full Text] [Related]
32. AUStralian study of titration to effect profile of safety (AUS-STEPS): high-dose gabapentin (neurontin) in partial seizures.
Beran R; Berkovic S; Black A; Danta G; Dunne J; Frasca J; Grainger K; Kilpatrick C; McKenzie R; McLaughlin D; Schapel G; Somerville E
Epilepsia; 2001 Oct; 42(10):1335-9. PubMed ID: 11737169
[TBL] [Abstract][Full Text] [Related]
33. An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly.
Saetre E; Perucca E; Isojärvi J; Gjerstad L;
Epilepsia; 2007 Jul; 48(7):1292-302. PubMed ID: 17561956
[TBL] [Abstract][Full Text] [Related]
34. Double-blind study of Gabapentin in the treatment of partial seizures.
Sivenius J; Kälviäinen R; Ylinen A; Riekkinen P
Epilepsia; 1991; 32(4):539-42. PubMed ID: 1907907
[TBL] [Abstract][Full Text] [Related]
35. Clinical efficacy and safety of gabapentin.
Ramsay RE
Neurology; 1994 Jun; 44(6 Suppl 5):S23-30; discussion S31-2. PubMed ID: 8022537
[TBL] [Abstract][Full Text] [Related]
36. Overview of the safety of newer antiepileptic drugs.
Shorvon S; Stefan H
Epilepsia; 1997; 38 Suppl 1():S45-51. PubMed ID: 9092960
[TBL] [Abstract][Full Text] [Related]
37. Pregabalin monotherapy for epilepsy.
Zhou Q; Zheng J; Yu L; Jia X
Cochrane Database Syst Rev; 2012 Oct; 10():CD009429. PubMed ID: 23076957
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ;
Neurology; 2004 Apr; 62(8):1261-73. PubMed ID: 15111660
[TBL] [Abstract][Full Text] [Related]
39. Effect of gabapentin on the anticonvulsant activity of antiepileptic drugs against electroconvulsions in mice: an isobolographic analysis.
Borowicz KK; Swiader M; Luszczki J; Czuczwar SJ
Epilepsia; 2002 Sep; 43(9):956-63. PubMed ID: 12199720
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
